Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo-Reference-Cited by-同舟云学术

Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo

Published:2012-01-03 Issue:5 Volume:131 Page:E781-E790
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Lee Justin B.,Zhang Kaixin,Tam Yuen Yi C.,Tam Ying K.,Belliveau Nathan M.,Sung Vanessa Y.C.,Lin Paulo J.C.,LeBlanc Eric,Ciufolini Marco A.,Rennie Paul S.,Cullis Pieter R.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2010

2. Androgen receptor is a tumor suppressor and proliferator in prostate cancer;Niu;Proc Natl Acad Sci USA,2008

3. The patient with hormone-refractory prostate cancer: determining who, when, and how to treat;Kent;Urol J,2003

4. Future directions in the treatment of androgen-independent prostate cancer;Petrylak;Urol J,2003

5. Utilizing RNA interference to enhance cancer drug delivery;Iorns;Nat Rev Drug Discov,2006

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease;European Journal of Neuroscience;2024-04-15

2. Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol;Journal of Controlled Release;2024-02

3. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals;Advanced Materials;2023-12-31

4. siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway;Future Oncology;2023-09

5. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery;Biomaterials;2023-08